Skip to main content

Kinney Gene G.'s Form 4 filing

Prothena Corp Public Ltd Co (PRTA) · filed May 17, 2023

Accession no.
0001140361-23-025344
Filed
May 17, 2023
Trade date
May 17, 2023
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.32M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kinney Gene G.CIK 0001564380Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 17, 2023Ordinary Shares, par value $0.01 per shareMOption exerciseAcquired+45,000$29.81+$1,341,45057,793Direct
May 17, 2023Ordinary Shares, par value $0.01 per shareSSaleDisposed−10,202$72.70F2−$741,685.447,591Direct
May 17, 2023Ordinary Shares, par value $0.01 per shareSSaleDisposed−19,864$73.60F3−$1,461,990.427,727Direct
May 17, 2023Ordinary Shares, par value $0.01 per shareSSaleDisposed−14,934$74.49F4−$1,112,433.6612,793Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 17, 2023Ordinary SharesMOption exerciseDisposed−45,000$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The transaction was executed in multiple trades in prices ranging from $72.06 to $73.055, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 4 of this Form 4.

Referenced by the price of 1 transaction in Table I.

F3

The transaction was executed in multiple trades in prices ranging from $73.06 to $74.05, inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The transaction was executed in multiple trades in prices ranging from $74.06 to $74.99, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)